WO1999051256A3 - Use of l-glu-l-trp in the treatment of hiv infection - Google Patents
Use of l-glu-l-trp in the treatment of hiv infection Download PDFInfo
- Publication number
- WO1999051256A3 WO1999051256A3 PCT/US1999/007297 US9907297W WO9951256A3 WO 1999051256 A3 WO1999051256 A3 WO 1999051256A3 US 9907297 W US9907297 W US 9907297W WO 9951256 A3 WO9951256 A3 WO 9951256A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- trp
- glu
- treatment
- hiv infection
- xaa
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002326760A CA2326760A1 (en) | 1998-04-03 | 1999-04-02 | Use of l-glu-l-trp in the treatment of hiv infection |
AU34667/99A AU3466799A (en) | 1998-04-03 | 1999-04-02 | Use of l-glu-l-trp in the treatment of hiv infection |
EP99916320A EP1067951A2 (en) | 1998-04-03 | 1999-04-02 | Use of l-glu-l-trp in the treatment of hiv infection |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5509298A | 1998-04-03 | 1998-04-03 | |
US09/055,092 | 1998-04-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999051256A2 WO1999051256A2 (en) | 1999-10-14 |
WO1999051256A3 true WO1999051256A3 (en) | 1999-12-09 |
Family
ID=21995541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/007297 WO1999051256A2 (en) | 1998-04-03 | 1999-04-02 | Use of l-glu-l-trp in the treatment of hiv infection |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1067951A2 (en) |
AU (1) | AU3466799A (en) |
CA (1) | CA2326760A1 (en) |
WO (1) | WO1999051256A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0112969A (en) | 2000-08-04 | 2004-06-22 | Dmi Biosciences Inc | Method of using diketopiperazines and compositions containing them |
PL2537524T3 (en) | 2003-05-15 | 2017-01-31 | Ampio Pharmaceuticals, Inc. | Treatment of T-cell mediated diseases |
JP5856843B2 (en) | 2008-05-27 | 2016-02-10 | アンピオ ファーマシューティカルズ,インコーポレイテッド | Pharmaceutical composition using diketopiperazine |
JP2013537195A (en) | 2010-09-07 | 2013-09-30 | ディエムアイ アクイジション コーポレイション | Disease treatment |
ES2795803T3 (en) | 2011-10-10 | 2020-11-24 | Ampio Pharmaceuticals Inc | Degenerative arthropathy treatment |
WO2013055749A1 (en) | 2011-10-10 | 2013-04-18 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
EA201490737A1 (en) | 2011-10-28 | 2014-09-30 | Ампио Фармасьютикалз, Инк. | TREATMENT OF RHINITIS |
CA2906864A1 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
US9956217B2 (en) | 2014-08-18 | 2018-05-01 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
WO2016209969A1 (en) | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
US11027287B2 (en) * | 2018-07-30 | 2021-06-08 | Metso Minerals Industries, Inc. | Gyratory crusher including a variable speed drive and control system |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0423077A1 (en) * | 1989-10-05 | 1991-04-17 | POLIFARMA S.p.A. | Tripeptide compounds and their pharmaceutical use as immunomodulators |
WO1994020063A2 (en) * | 1993-03-04 | 1994-09-15 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
US5728680A (en) * | 1987-12-30 | 1998-03-17 | Cytoven J.V. | Methods for normalizing numbers of lymphocytes |
-
1999
- 1999-04-02 CA CA002326760A patent/CA2326760A1/en not_active Abandoned
- 1999-04-02 WO PCT/US1999/007297 patent/WO1999051256A2/en not_active Application Discontinuation
- 1999-04-02 AU AU34667/99A patent/AU3466799A/en not_active Abandoned
- 1999-04-02 EP EP99916320A patent/EP1067951A2/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5728680A (en) * | 1987-12-30 | 1998-03-17 | Cytoven J.V. | Methods for normalizing numbers of lymphocytes |
EP0423077A1 (en) * | 1989-10-05 | 1991-04-17 | POLIFARMA S.p.A. | Tripeptide compounds and their pharmaceutical use as immunomodulators |
WO1994020063A2 (en) * | 1993-03-04 | 1994-09-15 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
Non-Patent Citations (1)
Title |
---|
GILL PS ET AL: "Preliminary results of a randomized study of IM-862 nasal solution in the treatment of patients with AIDS-related Kaposi's sarcoma", BLOOD, vol. 90, no. 10, 15 November 1997 (1997-11-15), pages 135a, XP002118779 * |
Also Published As
Publication number | Publication date |
---|---|
AU3466799A (en) | 1999-10-25 |
CA2326760A1 (en) | 1999-10-14 |
WO1999051256A2 (en) | 1999-10-14 |
EP1067951A2 (en) | 2001-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0955044A3 (en) | Method of inhibiting bacterial or fungal growth using a complexing agent | |
WO2003000200A3 (en) | β-2'-OR 3'-HALONUCLEOSIDES | |
TW371628B (en) | Composition for treating condyloma acuminata | |
AU635358B2 (en) | Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole | |
SE9504077D0 (en) | Liquid absorbent article considered for single use | |
IE891798L (en) | Novel ó-glucosidase inhibitors | |
EP1273298A3 (en) | Ritonavir in combination with an additional HIV protease inhibitor for treating aids | |
ES2136723T3 (en) | USE OF N-ARYL-METHYLENE-ETHYL-DIAMINE-TRIACETATES, N-ARYL-METHYLENE-IMINO-DIACETATES OR N, N'-DIARYL-METHYLENE-DIAMINE-ACETATES AGAINST OXIDIZING STRESS. | |
AU2001247968A1 (en) | Use of asiatic acid or asiaticoside for treatment of cancer | |
AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
WO1999051256A3 (en) | Use of l-glu-l-trp in the treatment of hiv infection | |
HK1068106A1 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
AU1067599A (en) | Peptide compositions for the treatment and prevention of hiv infection | |
AU2002219881A1 (en) | Methods and compositions for the treatment of human immunodeficiency virus infection | |
TW327171B (en) | 2-heteroaryl-5 for prevention or treatment of HIV infection | |
AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
WO2002000208A3 (en) | Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents | |
MY124071A (en) | Treatment of viral disease in swine | |
EP0373771A3 (en) | New pharmaceutical uses for cystatins | |
EE03514B1 (en) | A combination of compounds for the treatment of HIV infection or AIDS, its use and a pharmaceutical composition | |
EP0385909A3 (en) | A kit or composition for the prevention or treatment of HIV-1 infections | |
WO1998044913A3 (en) | Compositions containing mkc-442 in combination with other antiviral agents | |
AU6877587A (en) | Expellants of phytopathogenic microbes | |
HK1017345A1 (en) | Dithiazoldioxides and the use thereof as microbicides | |
WO2000002579A3 (en) | Component b as angiogenic agent in combination with human growth factors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2326760 Country of ref document: CA Ref country code: CA Ref document number: 2326760 Kind code of ref document: A Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 34667/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999916320 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999916320 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999916320 Country of ref document: EP |